Oct
2026
Fiera Milano, Italy
Visit us
stand 10G37, CRO

Solvias AG

Exhibitor at CPHI Milan 2026
About Us

Solvias helps innovative companies advance their path to commercialization with CMC analytical solutions powered by deep scientific expertise and a relentless focus on customer success. With extensive experience in small molecules, biologics, and cell and gene therapies, our experts apply creativity and rigor to solve even the most complex analytical challenges. Customers gain a single, trusted partner through our GMP, GLP, and ISO-certified facilities across five global locations, conducting over 100 successful audits each year.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Switzerland
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
Contract Research Organisation (CRO)
Primary activities
Analytical Services
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 10G37, CRO

Products Featured at CPHI Milan 2026

  • Biological Analysis

    Product Biological Analysis

    Solvias provides high calibre microbiology, chemistry, toxicology and cell biology services according to GMP, CGMP (FDA), GLP and ISO 17025 standards.Testing for sterile and non-sterile products / Environmental testing / Specialised studies (antibiotics, integrity testing, alternative methods) / Endoxin an...
  • Biopharmaceutical Analysis

    Product Biopharmaceutical Analysis

    Solvias has a solid reputation with market-leading biopharmaceutical companies for the characterization and QC analysis of monoclonal antibodies (mAbs), glycoproteins, PEGylated proteins and peptides and biosimilars (follow-on biologics). This means that businesses of all sizes, even smaller biotechs, can ...
  • Analytical Services

    Product Analytical Services

    Solvias provides cGMP-compliant contract analytical services to help you ultimately provide safer products to consumers. We provide a comprehensive range of analytical services to the pharmaceutical, biotech, medical devices and cosmetics industry with similar regulatory requirements for raw materials, ...
  • Analytical Characterization Services

    Product Analytical Characterization Services

    Avoid surprises with robust analytical characterization: Solvias provides a thorough understanding of the physical, chemical, and performance properties of your product. We combine deep expertise with a broad range of capabilities to effectively assess the attributes that impact your product’s stability, p...
  • Analytical Method Development & Validation

    Product Analytical Method Development & Validation

    Minimize risk with early-stage analytical method development and validation: The successful launch of a new drug application hinges on your analytical method development. It is vital to establish a clear  understanding of method design and robustness early in the process to minimize risk. Solvias offe...

Solvias AG Resources (1)

  • Advancing Peptide Therapeutics

    Whitepaper Advancing Peptide Therapeutics

    Peptide therapeutics have emerged as a significant frontier in the pharmaceutical industry, offering promise in treating countless conditions with high specificity and efficacy. This potential is reflected in the rapid growth of the global peptide therapeutics market, driven by advances in peptide synthesis and a deepening understanding of peptide biology. Despite their promising therapeutic applications, peptides present unique analytical challenges, particularly when employing High-Performance Liquid Chromatography (HPLC).